306 related articles for article (PubMed ID: 29959327)
1. Harnessing synthetic lethality to predict the response to cancer treatment.
Lee JS; Das A; Jerby-Arnon L; Arafeh R; Auslander N; Davidson M; McGarry L; James D; Amzallag A; Park SG; Cheng K; Robinson W; Atias D; Stossel C; Buzhor E; Stein G; Waterfall JJ; Meltzer PS; Golan T; Hannenhalli S; Gottlieb E; Benes CH; Samuels Y; Shanks E; Ruppin E
Nat Commun; 2018 Jun; 9(1):2546. PubMed ID: 29959327
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Lethal Interactions of RECQ Helicases.
Datta A; Dhar S; Awate S; Brosh RM
Trends Cancer; 2021 Feb; 7(2):146-161. PubMed ID: 33041245
[TBL] [Abstract][Full Text] [Related]
3. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
4. Re-defining synthetic lethality by phenotypic profiling for precision oncology.
Akimov Y; Aittokallio T
Cell Chem Biol; 2021 Mar; 28(3):246-256. PubMed ID: 33631125
[TBL] [Abstract][Full Text] [Related]
5. Synthetic lethality-mediated precision oncology via the tumor transcriptome.
Lee JS; Nair NU; Dinstag G; Chapman L; Chung Y; Wang K; Sinha S; Cha H; Kim D; Schperberg AV; Srinivasan A; Lazar V; Rubin E; Hwang S; Berger R; Beker T; Ronai Z; Hannenhalli S; Gilbert MR; Kurzrock R; Lee SH; Aldape K; Ruppin E
Cell; 2021 Apr; 184(9):2487-2502.e13. PubMed ID: 33857424
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
7. MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
Sun C; Cao W; Qiu C; Li C; Dongol S; Zhang Z; Dong R; Song K; Yang X; Zhang Q; Kong B
J Hematol Oncol; 2020 Jan; 13(1):9. PubMed ID: 32005272
[TBL] [Abstract][Full Text] [Related]
8. Synthetic lethality guiding selection of drug combinations in ovarian cancer.
Heinzel A; Marhold M; Mayer P; Schwarz M; Tomasich E; Lukas A; Krainer M; Perco P
PLoS One; 2019; 14(1):e0210859. PubMed ID: 30682083
[TBL] [Abstract][Full Text] [Related]
9. Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Carbajosa S; Pansa MF; Paviolo NS; Castellaro AM; Andino DL; Nigra AD; García IA; Racca AC; Rodriguez-Berdini L; Angiolini V; Guantay L; Villafañez F; Federico MB; Rodríguez-Baili MC; Caputto BL; Drewes G; Madauss KP; Gloger I; Fernandez E; Gil GA; Bocco JL; Gottifredi V; Soria G
Clin Cancer Res; 2019 Jul; 25(13):4049-4062. PubMed ID: 30890549
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
11. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
12. A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality.
Parameswaran S; Kundapur D; Vizeacoumar FS; Freywald A; Uppalapati M; Vizeacoumar FJ
Trends Cancer; 2019 Jan; 5(1):11-29. PubMed ID: 30616753
[TBL] [Abstract][Full Text] [Related]
13. Predicting essential genes and synthetic lethality via influence propagation in signaling pathways of cancer cell fates.
Zhang F; Wu M; Li XJ; Li XL; Kwoh CK; Zheng J
J Bioinform Comput Biol; 2015 Jun; 13(3):1541002. PubMed ID: 25669329
[TBL] [Abstract][Full Text] [Related]
14. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract][Full Text] [Related]
15. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
Sinha S; Thomas D; Chan S; Gao Y; Brunen D; Torabi D; Reinisch A; Hernandez D; Chan A; Rankin EB; Bernards R; Majeti R; Dill DL
Nat Commun; 2017 May; 8():15580. PubMed ID: 28561042
[TBL] [Abstract][Full Text] [Related]
16. A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer.
Somarelli JA; Roghani RS; Moghaddam AS; Thomas BC; Rupprecht G; Ware KE; Altunel E; Mantyh JB; Kim SY; McCall SJ; Shen X; Mantyh CR; Hsu DS
Mol Cancer Ther; 2020 Dec; 19(12):2516-2527. PubMed ID: 33158998
[TBL] [Abstract][Full Text] [Related]
17. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS
Cancer Biol Ther; 2018; 19(12):1078-1087. PubMed ID: 30299205
[TBL] [Abstract][Full Text] [Related]
18. Mapping the landscape of synthetic lethal interactions in liver cancer.
Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
[TBL] [Abstract][Full Text] [Related]
19. Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer.
Magen A; Das Sahu A; Lee JS; Sharmin M; Lugo A; Gutkind JS; Schäffer AA; Ruppin E; Hannenhalli S
Cell Rep; 2019 Jul; 28(4):938-948.e6. PubMed ID: 31340155
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
Xiao J; Glasgow E; Agarwal S
Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]